Dow Jones Top Company Headlines at 1 PM ET: Danone to Buy Protein-Shake Maker Huel for $1.2 Billion | France's ...

Danone to Buy Protein-Shake Maker Huel for $1.2 Billion

Danone is scooping up the maker of plant-based food powders and meal-replacement drinks to bolster its nutrition portfolio.

----

France's TotalEnergies Walks Away From U.S. Offshore Wind

The energy company said it would no longer develop any offshore wind-power projects in the U.S. amid efforts by the Trump administration to curtail the sector.

----

David Simon, Mall King Who Was Both Feared and Admired, Dies at 64

As head of Simon Property Group, he defied critics who said that malls were dinosaurs.

----

Pfizer's Lyme Vaccine Shows Strong Efficacy, but Misses Mark in Study

The drugmaker is seeking regulatory review for the first new shot to combat the disease in decades.

----

Hyundai SUV Seat Defect Leads To Recall After One Child's Death, Four Injuries

The recall affects about 69,000 Hyundai Palisade models.

----

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia

Poste Italiane said the merger would create a national champion with services spanning logistics, distribution, data, connectivity and tech.

----

Victory Capital Rejects Reports of Client Pushback in Bid for Janus Henderson

Victory Capital Holdings pushed back against reports that major clients are uneasy with its bid for Janus Henderson, calling the claims misleading and part of an effort to undermine what it calls a superior offer.

----

Nvidia, Emerald AI Partner With Power Companies on New AI Factories

The facilities will operate as flexible energy assets, supporting power grids by modulating consumption and leveraging on-site generation and storage.

----

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

Pharmaceutical giant Pfizer and French vaccine maker Valneva reported positive topline results from their phase three study of a vaccine candidate for Lyme disease.

----

OpenAI Taps Former Meta Executive to Lead Ad Push

Dave Dugan is joining the AI company, which is seeking stronger ties to brands in an effort to boost its nascent ad business.

----

Novo Nordisk Begins Study of Lexicon Oral Obesity Drug

The study is investigating the safety and tolerability of LX9851, how it moves through the body and its physiological and biological impacts.

----

OnlyFans Owner Leo Radvinsky Dies at 43

The reclusive executive built the subscription service into an adult-content powerhouse.

----

Sinopec Says Has Enough Oil Inventory to Ensure Stable Production for Now

At the briefing, Sinopec executives said the Middle East crisis has significantly disrupted the global economic and trade landscape.

----

EU Says It Will Provisionally Apply South American Trade Deal from May 1

The European Union will provisionally apply its trade agreement with South American countries as lawmakers in the bloc are still waiting to ratify the accord.

----

Tripadvisor Adds New Directors as Part of Deal With Activist Starboard

Tripadvisor added two new directors to its board as part of a cooperation agreement with activist investor Starboard Value.

----

Tesla, SpaceX Plan to Build New Chip Factory in Texas

Elon Musk, who leads both companies, said the facility would supply chips for Tesla vehicles and SpaceX satellites.

----

Activist Elliott Builds Big Stake in Chip-Design Software Maker Synopsys

Elliott plans to engage with Synopsys to push the business to make more money from its software and services, according to people familiar with the matter.

----

Mark Zuckerberg Is Building an AI Agent to Help Him Be CEO

The Meta Platforms chief uses the tool to get information faster as the company seeks to embrace artificial intelligence in all it does.

----

EU Competition Chief Says Google Decision is Coming, Ahead of U.S. Tech Meetings

Teresa Ribera is set to meet Mark Zuckerberg of Meta, Google's Sundar Pichai and Open AI's Sam Altman in San Francisco, California, on Tuesday.


(END) Dow Jones Newswires

March 23, 2026 13:15 ET (17:15 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.

Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.

Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.

Popular

Sponsor Center